Pharmacodynamics of cisplatin in human head and neck cancer: correlation between platinum content, DNA adduct levels and drug sensitivity in vitro and in vivo

MLA

A.M.J. Fichtinger-Schepman, et al. Pharmacodynamics of Cisplatin in Human Head and Neck Cancer: Correlation between Platinum Content, DNA Adduct Levels and Drug Sensitivity in Vitro and in Vivo. Jan. 1999. EBSCOhost, https://doi.org/10.1038/sj.bjc.6690015.

APA

A.M.J. Fichtinger-Schepman, Boudewijn J.M. Braakhuis, A Kegel, M. J. P. Welters, A. J. Jacobs-Bergmans, W.J.F. van der Vijgh, & Robert A. Baan. (1999). Pharmacodynamics of cisplatin in human head and neck cancer: correlation between platinum content, DNA adduct levels and drug sensitivity in vitro and in vivo. https://doi.org/10.1038/sj.bjc.6690015

Chicago

A.M.J. Fichtinger-Schepman, Boudewijn J.M. Braakhuis, A Kegel, M. J. P. Welters, A. J. Jacobs-Bergmans, W.J.F. van der Vijgh, and Robert A. Baan. 1999. “Pharmacodynamics of Cisplatin in Human Head and Neck Cancer: Correlation between Platinum Content, DNA Adduct Levels and Drug Sensitivity in Vitro and in Vivo,” January. doi:10.1038/sj.bjc.6690015.